Tripelennamine (sold as Pyribenzamine by Novartis) is a psychoactive drug and member of the pyridine and ethylenediamine classes that is used as an antipruritic and first-generation antihistamine. It can be used in the treatment of asthma hay fever rhinitus and urticaria but is now less common as it has been replaced by newer antihistamines.
This page contains content from the copyrighted Wikipedia article "Tripelennamine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
